// App-Quantinova.ai

195 : Copers and catastrophisers: coping strategies are associated with patient-reported assessment of the severity and impact of Raynaud’s phenomenon in systemic sclerosis

Researchers

Presenter

  • John Pauling

Principal Investigators

  • Elizabeth Reilly

  • Theresa Smith

  • Tracey Frech

Medical Centers

  • Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom

  • Department of Pharmacy and Pharmacology, University of Bath, Bath, UNITED KINGDOM

  • Department of Health, University of Bath, Bath, UNITED KINGDOM

  • Rheumatology, University of Utah and Salt Lake Regional Veterans Affair Medical Center, Salt Lake City, UT

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Raynaud syndrome

  • Scleroderma

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved